Return On Equity of Verrica Pharmaceuticals Inc. from 30 Sep 2018 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Verrica Pharmaceuticals Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 31 Dec 2025.
  • Verrica Pharmaceuticals Inc. Return On Equity for the quarter ending 31 Dec 2025 was 252%, a 54% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2025 was 252%, a 54% decline from 2024.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2024 was 550%.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2023 was -147%, a 90% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Verrica Pharmaceuticals Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 252% -298% -54% 01 Oct 2025 31 Dec 2025
Q3 2025 165% -1138% -87% 01 Jul 2025 30 Sep 2025
Q2 2025 243% +935% 01 Apr 2025 30 Jun 2025
Q1 2025 348% +620% 01 Jan 2025 31 Mar 2025
Q4 2024 550% +697% 01 Oct 2024 31 Dec 2024
Q3 2024 1304% +1399% 01 Jul 2024 30 Sep 2024
Q2 2024 -692% -646% -1413% 01 Apr 2024 30 Jun 2024
Q1 2024 -271% -217% -398% 01 Jan 2024 31 Mar 2024
Q4 2023 -147% -70% -90% 01 Oct 2023 31 Dec 2023
Q3 2023 -95% -1% -1.1% 01 Jul 2023 30 Sep 2023
Q2 2023 -46% +97% +68% 01 Apr 2023 30 Jun 2023
Q1 2023 -54% +58% +52% 01 Jan 2023 31 Mar 2023
Q4 2022 -77% -2.5% -3.4% 01 Oct 2022 31 Dec 2022
Q3 2022 -94% -12% -15% 01 Jul 2022 30 Sep 2022
Q2 2022 -142% -65% -83% 01 Apr 2022 30 Jun 2022
Q1 2022 -113% -39% -52% 01 Jan 2022 31 Mar 2022
Q4 2021 -75% +21% +22% 01 Oct 2021 31 Dec 2021
Q3 2021 -82% -11% -15% 01 Jul 2021 30 Sep 2021
Q2 2021 -78% -23% -43% 01 Apr 2021 30 Jun 2021
Q1 2021 -74% -29% -64% 01 Jan 2021 31 Mar 2021
Q4 2020 -96% -58% -153% 01 Oct 2020 31 Dec 2020
Q3 2020 -71% -36% -103% 01 Jul 2020 30 Sep 2020
Q2 2020 -55% -22% -68% 01 Apr 2020 30 Jun 2020
Q1 2020 -45% -17% -59% 01 Jan 2020 31 Mar 2020
Q4 2019 -38% -8.4% -28% 01 Oct 2019 31 Dec 2019
Q3 2019 -35% -3.3% -10% 01 Jul 2019 30 Sep 2019
Q2 2019 -32% 01 Apr 2019 30 Jun 2019
Q1 2019 -28% 01 Jan 2019 31 Mar 2019
Q4 2018 -30% 01 Oct 2018 31 Dec 2018
Q3 2018 -32% 01 Jul 2018 30 Sep 2018

Verrica Pharmaceuticals Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 252% -298% -54% 01 Jan 2025 31 Dec 2025
2024 550% +697% 01 Jan 2024 31 Dec 2024
2023 -147% -70% -90% 01 Jan 2023 31 Dec 2023
2022 -77% -2.5% -3.4% 01 Jan 2022 31 Dec 2022
2021 -75% +21% +22% 01 Jan 2021 31 Dec 2021
2020 -96% -58% -153% 01 Jan 2020 31 Dec 2020
2019 -38% -8.4% -28% 01 Jan 2019 31 Dec 2019
2018 -30% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.